Blood pressure from mid-to late life and risk of incident dementia

Neurology

Volumn 89, Issue 24, 2017, Pages 2447-2454

  McGrath, Emer R ^a,b,c   Beiser, Alexa S ^d,e,f   DeCarli, Charles ^g   Plourde, Kendra L ^e   Vasan, Ramachandran S ^d,e,f   Greenberg, Steven M ^b,c   Seshadri, Sudha ^d,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f FRAMINGHAM HEART STUDY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; COGNITION; COHORT ANALYSIS; DEMENTIA; DEMOGRAPHY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ELEVATED BLOOD PRESSURE; FEMALE; FOLLOW UP; HEALTH STATUS; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SYSTOLIC HYPERTENSION; MULTIVARIATE ANALYSIS; PREHYPERTENSION; PROPORTIONAL HAZARDS MODEL; UNITED STATES;

ADULT; AGED; BLOOD PRESSURE; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREHYPERTENSION; PROPORTIONAL HAZARDS MODELS; UNITED STATES;

EID: 85038363244     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000004741     Document Type: Article

References (36)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013;9:63-75.e2.
2. Kennelly SP, Lawlor B, Kenny R. Blood pressure and the risk for dementia: a double edged sword. Ageing Res Rev 2009;8:61-70.
3. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42: 2672-2713.
4. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005;64:277-281.
5. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 2000;21:49-55.
6. Kivipelto M, Helkala EL, Laakso MP, et al. Apolipopro-tein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002;137:149-155.
7. Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol 2001;58:1640-1646.
8. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol 2003; 60:223-228.
9. Skoog I, Lernfelt B, Landahl S, et al. 15-Year longitudinal study of blood pressure and dementia. Lancet 1996;347: 1141-1145.
10. Tyas SL, Manfreda J, Strain LA, Montgomery PR. Risk factors for Alzheimer's disease: a population-based, longi tudinal study in Manitoba, Canada. Int J Epidemiol 2001; 30:590-597.
11. Ruitenberg A, Skoog I, Ott A, et al. Blood pressure and risk of dementia: results from the Rotterdam Study and the Gothenburg H-70 Study. Dement Geriatr Cogn Dis-ord 2001;12:33-39.
12. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003;61:1667-1672.
13. Stewart R, Xue QL, Masaki K, et al. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 2009;54:233-240.
14. Qiu C, von Strauss E, Winblad B, Fratiglioni L. Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project. Stroke 2004;35:1810-1815.
15. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP. The Framingham Offspring Study: design and preliminary data. Prev Med 1975;4:518-525.
16. Seshadri S, Wolf P, Beiser A, et al. Lifetime risk of dementia and Alzheimer's disease: the impact of mortality on risk estimates in the Framingham study. Neurology 1997;49: 1498-1504.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington: American Psychiatric Association; 1994.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
19. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2571.
20. Forette F, Seux M-L, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-1351.
21. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial Cognitive Function Assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7:683-689.
22. Anderson C, Teo K, Gao P, et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 2011;10:43-53.
23. Diener H-C, Sacco RL, Yusuf S, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 2008;7:875-884.
24. Pearce LA, McClure LA, Anderson DC, et al. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial. Lancet Neurol 2014;13:1177-1185.
25. Applegate WB, Pressel S, Wittes J, et al. Impact of the treatment of isolated systolic hypertension on behavioral variables: results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994;154:2154-2160.
26. Hornslien GA, Sandset CE, Bath MP, Wyller BT, Berge BE. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Can-desartan Acute Stroke Trial. Stroke 2013;44:2022-2024.
27. Moll van Charante EP, Richard E, Eurelings LS, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet 2016;388:797-805.
28. den Heijer T, Skoog I, Oudkerk M, et al. Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol Aging 2003;24:307-313.
29. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Carmelli D. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology 2000;54:2108-2114.
30. Muller M, Sigurdsson S, Kjartansson O, et al. Joint effect of mid-and late-life blood pressure on the brain: the AGES-Reykjavik study. Neurology 2014;82:2187-2195.
31. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke 1998;29:2334-2340.
32. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J 2006;82:357-362.
33. de la Torre J. Alzheimer disease as a vascular disorder nosological evidence. Stroke 2002;33:1152-1162.
34. Ishii M, Iadecola C. Metabolic and non-cognitive manifestations of Alzheimer's disease: the hypothalamus as both culprit and target of pathology. Cell Metab 2015; 22:761-776.
35. Iadecola C, Davisson RL. Hypertension and cerebrovascu-lar dysfunction. Cell Metab 2008;7:476-484.
36. Maillard P, Seshadri S, Beiser A, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol 2012;11:1039-1047.